Roumell Asset Management, LLC insider trades: Transcept Pharmaceuticals (TSPT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Roumell Asset Management, LLC reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 13, 2013 | TSPT | ↓ Sell | 1,470 | $3.54 | $5K | Fn | Dec 17, 2013 (4d) |
| Dec 11, 2013 | TSPT | ↓ Sell | 10,490 | $3.55 | $37K | Fn | Dec 12, 2013 (1d) |
| Dec 6, 2013 | TSPT | ↓ Sell | 8,710 | $3.54 | $31K | Fn | Dec 10, 2013 (4d) |
| Dec 4, 2013 | TSPT | ↓ Sell | 7,120 | $3.50 | $25K | Fn | Dec 5, 2013 (1d) |
| Nov 20, 2013 | TSPT | ↓ Sell | 10,040 | $3.57 | $36K | Fn | Nov 20, 2013 (0d) |
| Nov 12, 2013 | TSPT | ↓ Sell | 7,190 | $3.53 | $25K | Fn | Nov 13, 2013 (1d) |
| Nov 4, 2013 | TSPT | ↓ Sell | 2,380 | $3.75 | $9K | Fn | Nov 6, 2013 (2d) |
| Oct 30, 2013 | TSPT | ↓ Sell | 7,020 | $3.69 | $26K | Fn | Oct 30, 2013 (0d) |
| Oct 7, 2013 | TSPT | ↓ Sell | 750 | $3.60 | $3K | Fn | Oct 10, 2013 (3d) |
| Sep 25, 2013 | TSPT | ↓ Sell | 6,710 | $3.69 | $25K | Fn | Sep 27, 2013 (2d) |
| Feb 28, 2013 | TECUA | ↓ Sell | 14,370 | $9.19 | $132K | Fn | Mar 1, 2013 (1d) |
| Feb 28, 2013 | TECUB | ↓ Sell | 2,840 | $8.89 | $25K | Fn | Mar 1, 2013 (1d) |
| Feb 26, 2013 | TECUA | ↓ Sell | 7,590 | $9.22 | $70K | Fn | Feb 26, 2013 (0d) |
| Feb 26, 2013 | TECUB | ↓ Sell | 1,360 | $8.94 | $12K | Fn | Feb 26, 2013 (0d) |
| Feb 11, 2013 | TECUA | ↓ Sell | 8,320 | $7.97 | $66K | Fn | Feb 13, 2013 (2d) |
| Feb 11, 2013 | TECUB | ↓ Sell | 1,380 | $8.18 | $11K | Fn | Feb 13, 2013 (2d) |
| Feb 6, 2013 | TECUA | ↓ Sell | 11,200 | $7.77 | $87K | Fn | Feb 13, 2013 (7d) |
| Feb 6, 2013 | TECUA | ↓ Sell | 11,200 | $7.77 | $87K | Fn | Feb 8, 2013 (2d) |
| Feb 6, 2013 | TECUB | ↓ Sell | 2,030 | $8.08 | $16K | Fn | Feb 8, 2013 (2d) |
| Feb 1, 2013 | TECUA | ↓ Sell | 3,370 | $7.12 | $24K | Fn | Feb 5, 2013 (4d) |
| Feb 1, 2013 | TECUB | ↓ Sell | 370 | $7.20 | $3K | Fn | Feb 5, 2013 (4d) |
| Jan 28, 2013 | TECUA | ↓ Sell | 7,180 | $7.15 | $51K | Fn | Jan 30, 2013 (2d) |
| Jan 28, 2013 | TECUB | ↓ Sell | 1,020 | $7.30 | $7K | Fn | Jan 30, 2013 (2d) |
| Jan 15, 2013 | TECUA | ↓ Sell | 6,710 | $5.01 | $34K | Fn | Jan 17, 2013 (2d) |
| Jan 15, 2013 | TECUB | ↓ Sell | 1,110 | $4.95 | $5K | Fn | Jan 17, 2013 (2d) |
| Mar 13, 2006 | PTM | ↑ Buy | 164,250 | $8.09 | $1.3M | As an Investment Advisor | Mar 15, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Roumell Asset Management, LLC's insider trades
Roumell Asset Management, LLC is a 10% owner of Transcept Pharmaceuticals (TSPT). Since Mar 13, 2006, it has reported 1 open-market purchase worth $1.3M and 25 sales worth $854K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.